“…In recent years, increasing evidence revealed that dysregulation of several lncRNAs is closely associated with glioma development, progression, and treatment resistance [ [26] , [27] , [28] ]. For example, lncRNA LINREP linc-RoR has been identified as a pro-oncogenic molecule and promotes glioma progression [ 11 , 29 ]. Moreover, several lncRNAs including LINC00520, XLOC013218, and PDIA3P1, contribute to the acquisition of temozolomide resistance [ 10 , 30 , 31 ].…”